Recent Price Movements and Market Performance
On 12 Dec 2025, Deccan Health Care’s stock price declined by 9.54% in a single trading session, contrasting sharply with the Sensex’s positive movement of 0.45% on the same day. This drop contributed to a two-day consecutive fall, during which the stock lost 8.97% in value. Over the past week, the stock has recorded an 11.02% reduction, while the Sensex showed a marginal decline of 0.60%.
Looking at broader time frames, the stock’s performance remains subdued. Over one month, the share price has moved down by 14.56%, whereas the Sensex gained 0.87%. The three-month period shows a 29.56% decline for Deccan Health Care, in contrast to a 4.02% rise in the benchmark. The one-year performance reveals a 55.38% reduction in the stock’s value, while the Sensex appreciated by 4.81%.
Year-to-date figures indicate a 53.64% fall for the stock, compared with a 9.03% gain in the Sensex. Over three and five years, the stock has declined by 66.48% and 62.59% respectively, while the Sensex has recorded gains of 37.13% and 84.82% in the same periods. Notably, over a ten-year horizon, Deccan Health Care’s stock price has remained flat, whereas the Sensex surged by 240.19%.
Technical Indicators and Trading Trends
Deccan Health Care is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This positioning indicates sustained downward momentum and a lack of short- to long-term price support. The stock’s underperformance relative to its healthcare services sector by 6.64% today further highlights its relative weakness in the market.
Perfect timing to enter! This Small Cap from IT - Software just turned profitable with growth momentum clearly building up. Get in before the broader market notices!
- - New profitability achieved
- - Growth momentum building
- - Under-the-radar entry
Fundamental Metrics and Financial Health
Deccan Health Care’s long-term fundamental strength is reflected in an average Return on Equity (ROE) of 1.43%, which is modest within the healthcare services sector. The company’s capacity to meet interest obligations is limited, with an average EBIT to interest ratio of 1.84, indicating constrained earnings relative to debt servicing requirements.
Despite the stock’s price decline, the company has reported positive results for the last three consecutive quarters. Operating cash flow for the year reached a peak negative value of ₹6.43 crores, signalling cash outflows from core business activities. Net sales for the latest six-month period stood at ₹43.54 crores, showing a growth rate of 28.51%. The inventory turnover ratio for the half-year was recorded at 1.84 times, the highest in recent periods, suggesting some improvement in inventory management.
Valuation and Shareholding Pattern
The stock’s valuation metrics indicate a Price to Book Value ratio of 0.3, which is lower than the average historical valuations of its peers in the healthcare services sector. This suggests that the market is pricing the stock at a discount relative to its book value. The ROE of 1.3% further supports the notion of an attractive valuation from a purely numerical perspective.
Majority shareholding in Deccan Health Care is held by non-institutional investors, which may influence liquidity and trading dynamics in the stock.
Considering Deccan Health Care ? Wait! SwitchER has found potentially better options in Healthcare Services and beyond. Compare this micro-cap with top-rated alternatives now!
- - Better options discovered
- - Healthcare Services + beyond scope
- - Top-rated alternatives ready
Comparative Performance Against Benchmarks
Deccan Health Care’s stock has consistently underperformed the BSE500 index over the last three annual periods. The cumulative returns over one year show a decline of 55.38%, while the BSE500 and Sensex indices have recorded positive returns in the same timeframe. This persistent underperformance highlights the challenges faced by the company in generating shareholder value relative to broader market benchmarks.
Profitability trends over the past year show a reduction in profits by 9%, which aligns with the downward trajectory in the stock price. This combination of declining profits and sustained price weakness underscores the pressures on the company’s financial and market standing.
Summary of Current Situation
Deccan Health Care’s stock reaching an all-time low of ₹13.5 reflects a prolonged period of subdued performance and market sentiment. The stock’s position below all major moving averages, coupled with significant underperformance relative to sector and benchmark indices, illustrates the extent of the decline. While the company has reported some positive quarterly results and sales growth, these have not translated into improved market valuation or investor confidence.
The company’s financial ratios indicate modest returns on equity and limited capacity to cover interest expenses, factors that contribute to the cautious market stance. The valuation discount relative to peers suggests that the market is pricing in ongoing risks and uncertainties surrounding the company’s prospects.
Investors and market participants will continue to monitor Deccan Health Care’s financial disclosures and market movements closely as the stock navigates this challenging phase.
Only ₹14,999 - Get MojoOne + Stock of the Week for 2 Years PLUS 6 Months FREE Claim 83% OFF →
